INFORMATION FOR
News
Obesity, which is on the rise worldwide, has been linked to colon cancer but the mechanism has been a mystery. In a new study, Yale researchers and their co-authors have uncovered how obesity drives tumor growth in mice, revealing potential strategies to combat the disease.
Women’s Health Research at Yale (WHRY) today announced funding for studies to tackle ovarian cancer, heart attacks, obesity, and the effect of cannabis on the brain.
It is well documented that a healthy diet and exercise are key in cancer prevention and management, but the exact mechanism hasn’t been clear. Now, Yale Cancer Center researchers have found an explanation in the tiny protective ends of chromosomes called telomeres. The findings were presented Dec. 11 at the 2015 San Antonio Breast Cancer Symposium.
Yale cancer scientist Melinda Irwin says that the connection between obesity and cancer are so strong -- as are recent findings about the effectiveness of exercise and diet in treating cancer -- that pharmaceutical companies should be required to include these two lifestyle components in drug trials.
WINS Trial: Weight Loss from Low-Fat Diet Improves Survival in HR-Negative Breast Cancer
A recent study from the Yale School of Public Health shows increased endometrial cancer mortality rates in women with body mass index levels above the healthy range of 18.5 to 24.9.
In a Q&A, Mireille Serlie, MD, PhD, discusses the effects of eating patterns on the brain, the risks of being frequently exposed to high-sucrose and high-fat foods, and recommendations for adopting healthy eating habits.
In a Q&A, Ania Jastreboff, MD, PhD, discusses the barriers to treating obesity, benefits of clinical trials, and the new era of obesity medicine.
Ania Jastreboff, MD, PhD, Director, Yale Obesity Research Center (Y-Weight); Co-Director, Yale Center for Weight Management, is interviewed by WTNH-TV on muscle loss while losing weight.
Low albumin levels were associated with an increased rate of serious surgical complications and comorbidities.
Kasia Lipska, MD, MHS, was one of five experts invited to testify at the Senate Health, Education, Labor, and Pensions (HELP) Committee hearing on December 14, 2023.
Bariatric surgeon Dr. Neil Floch speaks with Kate Bauman about the treatments surrounding obesity.
Patients who could benefit from popular obesity and Type 2 diabetes drugs are unable to get them due to disparities.
The SELECT trial findings suggest a weight loss drug could lower the risk of heart disease by 20 percent.
The shifts in attitude about obesity can also be seen in the KFF survey, said Dr. Ania Jastreboff, an endocrinologist and obesity-medicine specialist at Yale University and a consultant for the makers of the new drugs. After decades of hearing that losing weight was just a matter of exerting willpower, most of the public is intensely interested in medical treatments.
Rachel Perry, PhD, assistant professor of medicine (endocrinology) and of cellular and molecular physiology, received the Endocrinology and Metabolism Section New Investigator Award from the American Physiological Society (APS) during its summit on April 21.
Sedentary time at an extraordinary level. Harlan Krumholz, MD , says we need a large-scale societal shift where daily movement is the norm.
In today’s health headlines, what to know about a new Omicron subvariant, and how Americans are snacking more than ever. What this means for our health, and the link between asthma and obesity. Dr. Nate Wood, Yale Medicine Internal Medicine specialist and instructor at Yale School of Medicine, discussed these topics.
Millions of U.S. adults who are overweight or obese are unable to afford the latest treatment in obesity medicine, a study by the Yale School of Medicine has found.
Harlan Krumholz joins Shep Smith to discuss new recommendations regarding aspirin and heart disease, and diabetes testing for obese adults age 35 and over.